Sale disclosed
Mary Miller
Chief Legal Officer
Common Stock
- Reported value
- $585.06
- Reported price
- $1.99 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Acrivon Therapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $585.06 by 1 insider.
Showing the first 6 of 10 trades on this page.
Chief Legal Officer
Common Stock
President and CEO; EVP - Business Operations
Common Stock
Chief Accounting Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Development Officer
Common Stock
Chief Operating Officer
Common Stock
President and CEO; EVP - Business Operations
Common Stock
President and CEO; EVP - Business Operations
Common Stock
Chief Financial Officer
Common Stock
Chief Legal Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Legal Officer | Common StockSale | 294$1.99 / share | $585.06 | Oct 5Filed Oct 7 · 2d later | SEC filing |
| +1President and CEO; EVP - Business Operations | Common StockSale | 14,036$2.21 / share | $30.97K | Aug 25Filed Aug 27 · 2d later | SEC filing |
| Chief Accounting Officer | Common StockSale | 101$2.01 / share | $203.01 | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Legal Officer | Common StockSale | 185$2.01 / share | $371.85 | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Development Officer | Common StockSale | 400$2.01 / share | $804 | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Operating Officer | Common StockSale | 604$2.01 / share | $1.21K | Aug 18Filed Aug 20 · 2d later | SEC filing |
| +1President and CEO; EVP - Business Operations | Common StockSale2 trades | 1,713avg $2.01 / share | $3.44K | Aug 18Filed Aug 20 · 2d later | 2 filings
|
| Chief Financial Officer | Common StockSale | 1,142$1.57 / share | $1.79K | Aug 4Filed Aug 6 · 2d later | SEC filing |
| Chief Legal Officer | Common StockSale | 573$1.76 / share | $1.01K | Jul 21Filed Jul 23 · 2d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.